Kala Bio (KALA) Interest Coverage Ratio (2016 - 2025)
Kala Bio's (KALA) quarterly Interest Coverage Ratio came in at 72.52 in Q4 2025, down 967.18% year-over-year from 8.36 in Q4 2024, and down 864.7% quarter-over-quarter from 7.52 in Q3 2025.
Analysis
Kala Bio (KALA) Interest Coverage Ratio (2016 - 2025) Analysis & Trends
Kala Bio has disclosed Interest Coverage Ratio across 10 years of filings, most recently posting 72.52 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio fell 967.18% year-over-year to 72.52; the TTM figure through Dec 2025 stood at 11.95 (down 68.68% YoY), while the FY2025 annual figure was 11.95, down 68.68% from the prior year.
- Interest Coverage Ratio came in at 72.52 for Q4 2025 at Kala Bio, down from 7.52 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 6.01 in Q3 2023 to a low of 72.52 in Q4 2025.
- Average Interest Coverage Ratio over 5 years is 13.07, with a median of 8.99 recorded in 2024.
- Year-over-year, Interest Coverage Ratio soared 71.17% in 2022 and tumbled 967.18% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 22.55 in 2021, then soared by 71.17% to 6.5 in 2022, then decreased by 0.8% to 6.55 in 2023, then fell by 3.71% to 6.8 in 2024, then plunged by 967.18% to 72.52 in 2025.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 72.52 in Q4 2025, 7.52 in Q3 2025, and 10.2 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.55 Bn | 192.56 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 180.15 Bn | 176.98 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 131.59 Bn | 123.73 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.98 Bn | 73.98 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.33 Bn | 55.14 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 53.75 Bn | 48.61 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.06 Bn | 29.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.95 Bn | 30.67 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.25 Bn | 29.25 Bn | 1.16 Mn | - |
| 10 | Kala Bio | 8.44 Mn | 8.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -72.52 |
| Sep 30, 2025 | -7.52 |
| Jun 30, 2025 | -10.20 |
| Mar 31, 2025 | -9.78 |
| Dec 31, 2024 | -6.80 |
| Sep 30, 2024 | -6.76 |
| Jun 30, 2024 | -6.59 |
| Mar 31, 2024 | -8.20 |
| Dec 31, 2023 | -6.55 |
| Sep 30, 2023 | -6.01 |
| Jun 30, 2023 | -6.79 |
| Mar 31, 2023 | -7.93 |
| Dec 31, 2022 | -6.50 |
| Sep 30, 2022 | -10.07 |
| Jun 30, 2022 | -11.77 |
| Mar 31, 2022 | -15.19 |
| Dec 31, 2021 | -22.55 |
| Sep 30, 2021 | -12.58 |
| Jun 30, 2021 | -13.89 |
| Mar 31, 2021 | -13.22 |